• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

FibroGen, Inc - Common Stock (NQ:FGEN)

9.710 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about FibroGen, Inc - Common Stock

< Previous 1 2 3 Next >
Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS
May 08, 2024
Via AB Newswire
News headline image
FIBROGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating FibroGen, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 26, 2023
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Fibrogen, Inc. and Encourages Investors With Losses to Contact the Firm
June 27, 2023
From The Schall Law Firm
Via Business Wire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FibroGen, Inc. and Encourages Investors with Losses to Contact the Firm
June 26, 2023
From The Schall Law Firm
Via Business Wire
News headline image
Why did Sarepta Therapeutics Stock Plummet?
March 21, 2023
SRPT stock fell 20% after the FDA changed course on their new DMD treatment approval. The stock remains strong with an encouraging outlook and a mod Buy rating. 
Via MarketBeat
News headline image
FIBROGEN INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Provides Update of its Investigation of the Officers and Directors of FibroGen, Inc. - FGEN
August 19, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
FIBROGEN INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Provides Update of its Investigation of the Officers and Directors of FibroGen, Inc. - FGEN
July 22, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
FibroGen, Inc. (NASDAQ:FGEN) Investor Alert: Investigation over Potential Wrongdoing ↗
June 24, 2022
San Diego, CA -- (SBWIRE) -- 06/24/2022 -- An investigation was announced for current long-term investors in shares of FibroGen, Inc. (NASDAQ:FGEN) over potential breaches of fiduciary duties by... 
Via SBWire
News headline image
FIBROGEN INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of FibroGen, Inc. - FGEN
May 27, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
FIBROGEN INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of FibroGen, Inc. - FGEN
May 05, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
NASDAQ:FGEN Long Term Investor Notice: Lawsuit Filed Against Certain Directors of FibroGen, Inc ↗
May 05, 2022
San Diego, CA -- (SBWIRE) -- 05/05/2022 -- An investor in FibroGen, Inc. (NASDAQ:FGEN) shares filed a lawsuit against certain directors of FibroGen, Inc over alleged breaches of fiduciary duties. 
Via SBWire
News headline image
FIBROGEN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of FibroGen, Inc. - FGEN
April 29, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
FIBROGEN ALERT: Bragar Eagel & Squire, P.C. Is Investigating Fibrogen, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 15, 2021
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
NASDAQ: FGEN Long Term Investor Alert: Investigation of Potential Wrongdoing at FibroGen, Inc. ↗
August 20, 2021
San Diego, CA -- (SBWIRE) -- 08/20/2021 -- An investigation on behalf of current long term investors in FibroGen, Inc. (NASDAQ: FGEN) shares over possible breaches of fiduciary duty by certain officers... 
Via SBWire
Topics Lawsuit
News headline image
DEADLINE TODAY: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
June 11, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
FIBROGEN CLASS ACTION REMINDER
June 10, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
DEADLINE TOMORROW: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
June 10, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against FibroGen, Inc. and Encourages Investors to Contact the Firm
June 09, 2021
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
FIBROGEN SHAREHOLDER NOTICE
June 09, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
FGEN Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors or June 11, 2021 Deadline in Securities Fraud Class Action Lawsuit
June 09, 2021
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN)
June 09, 2021
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
FRIDAY DEADLINE NOTICE: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
June 09, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
FIBROGEN 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against FibroGen, Inc. - FGEN
June 08, 2021
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
FIBROGEN SHAREHOLDER ALERT
June 08, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
FibroGen, Inc. (NASDAQ:FGEN) Investor Notice: Deadline in Lawsuit on June 11, 2021 ↗
June 08, 2021
San Diego, CA -- (SBWIRE) -- 06/08/2021 -- A deadline is coming up on June 11, 2021 in the lawsuit filed for certain investors of FibroGen, Inc. (NASDAQ:FGEN). 
Via SBWire
Topics Lawsuit
News headline image
FGEN Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds FibroGen, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
June 08, 2021
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
FRIDAY DEADLINE REMINDER: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
June 08, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
FIBROGEN DEADLINE ALERT
June 07, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
FRIDAY DEADLINE ALERT: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
June 07, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
FIBROGEN UPDATE
June 06, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap